Mayur is finishing his Ph.D in Biomedical Engineering at Columbia University where he cofounded Ardent Cell Technologies, a cell therapeutics company entering clinical trials. Before joining Columbia he worked at Boston Consulting Group designing predictive models and precision medicine product pipelines for healthcare giants like Boston Scientific. He believes that opportunities shaping and contributing towards value based care are the way forward.
Anytime you go to a conference or a competition, they ask you, ?What?s your revenue model?? After having done, I think, eight or nine companies, that?s one thing which doesn?t matter. You see the product market fit. You know you?re creating value. You should have a fair idea as to what the reven...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
